Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3Stomach Neoplasms 2Sarcoma 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Smoking Cessation 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Neurofibrosarcoma 1Neoplasm Metastasis 1Mucopolysaccharidosis I 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Glioblastoma 1Fibrosarcoma 1Colorectal Neoplasms 1Cachexia 1Breast Neoplasms 1

Interventions

Gemcitabine 358Fluorouracil 94Oxaliplatin 81Capecitabine 74130-nm albumin-bound paclitaxel 71Albumin-Bound Paclitaxel 70Radiotherapy 67Leucovorin 58Irinotecan 49Erlotinib Hydrochloride 47Cisplatin 44Bevacizumab 31pembrolizumab 30Radiosurgery 30Docetaxel 26Taxes 24Nivolumab 24Cetuximab 24Pancreaticoduodenectomy 20Drug Therapy 17folfirinox 16Cyclophosphamide 16Radiation 15Ipilimumab 13Endoscopic Ultrasound-Guided Fine Needle Aspiration 13Surgical Procedures, Operative 12Sorafenib 12Paclitaxel 12Neoadjuvant Therapy 12irinotecan sucrosofate 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pancreatic Neoplasms × Combined Modality Therapy × Clear all
NCT06967233 2025-05-13

Multimodal Managements for Metastatic Pancreatic Cancer.

Zhejiang University

Completed
360 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡